3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
15
Colorectal Neoplasms
15
Pancreatic Neoplasms
11
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Esophageal Neoplasms
6
Rectal Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Anus Neoplasms
4
Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Peritoneal Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Observation
×
Gastrointestinal
×
Clear all
NCT06933966
2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2
Not yet recruiting
120 enrolled